Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREXO: Genetic Susceptibility in Ocular Toxoplasmosis
NCT02863588Terminated
- Sponsor
- Strasbourg University Hospital
- Start
- Mar 2017
- Primary completion
- Nov 2019
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Strasbourg University Hospital. Primary endpoint: Highlighting of genetic mutations associated with the susceptibility to Toxoplasma gondii severe eye recurrences at Day 1. Started Mar 2017; status: terminated.
Beyond the preview
Go deeper on NCT02863588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02863588.